Drug Discovery Informatics Market Report 2026

Drug Discovery Informatics Market Overview

• Drug Discovery Informatics market size has reached to $4.06 billion in 2025 • Expected to grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 13.7% • Growth Driver: The Impact Of Chronic Disease Prevalence On The Growth Of Informatics Solutions • Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Discovery Informatics Market?

Drug discovery informatics is the development of systems that can operate more efficiently with such enormous volumes of clinical trial and treatment data. Drug discovery informatics will assist in managing medical information and can make the process of studying and developing successful new treatments faster and more efficient. The main services offered in drug discovery informatics include in-house and outsourced. In-house computer or software refers to computer programs in both source and object code form that is relevant to the group's business and are utilized by the company and were produced by the company rather than licensed by third parties. The various modalities include cloud-based systems and in-campus for applications such as data sequencing, molecular docking, identification and validation and target data analysis for end-users such as pharmaceutical companies, contract research organizations and biotechnology companies.

What Is The Drug Discovery Informatics Market Growth Forecast?

The drug discovery informatics market size is expected to see rapid growth in the next few years. It will grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increasing investments in ai-enabled drug discovery, rising adoption of precision medicine approaches, expansion of collaborative research platforms, growing focus on predictive modeling accuracy, increasing integration of informatics with laboratory systems. Major trends in the forecast period include increasing use of ai-driven drug discovery platforms, rising adoption of cloud-based informatics solutions, growing integration of big data analytics in r&d, expansion of virtual screening and modeling tools, enhanced focus on data integration and management.

Global Drug Discovery Informatics Market Segmentation

1) By Service: In-House, Outsourced 2) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis 3) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies Subsegments: 1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling 2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services

What Is The Driver Of The Drug Discovery Informatics Market?

The rising prevalence of various chronic diseases is expected to propel the growth of the drug discovery informatics market going forward. Chronic illnesses are described generically as disorders that persist for a year or longer and need continuing medical treatment, impede everyday activities or both. Drug discovery informatics systems aid in the advancement of chronic illness care by allowing researchers to probe more complex and transient molecular changes that underpin disease progression and drug response, resulting in multi-dimensional models of the entire hierarchical system in healthy, diseased, and treated states. For instance, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based patient, healthcare professional, and research charity, around 4.4 million people in the UK were living with a diabetes diagnosis as of 2022-23. Among these cases, approximately 8% had type 1 diabetes, while type 2 diabetes accounted for about 90%. Therefore, the rising prevalence of various chronic diseases is driving the growth of the drug discovery informatics industry.

Key Players In The Global Drug Discovery Informatics Market

Major companies operating in the drug discovery informatics market are Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.; Eurofins DiscoverX Products Inc.; Jubilant Biosys Ltd.; Selvita S.A.; PerkinElmer Inc.; International Business Machines Corporation; Boehringer Ingelheim International GmbH; Oracle Corporation; Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; ChemAxon Ltd.; Amazon Web Services Inc.; Schrödinger LLC.; Core Informatics LLC; Informatics Matters Ltd.; Tata Consultancy Services Limited; Novo Informatics Pvt. Ltd.; IO Informatics Inc.; GVK Biosciences Private Limited; Dassault Systèmes SE; Recursion Pharmaceuticals Inc.; Cyclica Inc.; Valence Discovery Inc.; Valo Health Inc.; Cognizant Technology Solutions Corporation; Wipro Limited; Mindtree Limited; Persistent Systems Limited; Mphasis Limited

Global Drug Discovery Informatics Market Trends and Insights

Major companies operating in the drug discovery informatics market are focusing on innovative products such as AI-powered life sciences solutions to drive revenues in their market. Artificial intelligence (AI)-driven life sciences solutions are advancing precision medicine and drug discovery, with the potential to completely transform the creation of novel therapies and individualized treatment plans to improve the speed, precision, and efficiency of the life sciences industry's research and development procedures. For instance, in May 2023, Google Cloud Platform, a US-based technology company launched AI-powered life sciences solutions, target and lead identification suite, and the multiomics suite. These are intended to revolutionize life sciences companies by speeding up drug research and accelerating the release of new treatments. These methods anticipate protein structures, determine the role of amino acids, and analyze genetic data by utilizing high-performance computers, generative AI, and sophisticated computational tools. Multiomics suite aids in the development of precision medicine tools, the target and lead identification suite facilitate more effective in silico drug design.

What Are Latest Mergers And Acquisitions In The Drug Discovery Informatics Market?

In May 2023, Recursion Pharmaceuticals, a US-based clinical-stage biotechnology company, acquired Cyclica Inc. for $40 million. As a result of the acquisition, Recursion enhanced its technology-driven drug discovery capabilities by integrating Cyclica’s digital chemistry expertise with its own biological exploration strengths. Cyclica Inc. is a Canada-based company specializing in drug discovery informatics.

Regional Insights

North America was the largest region in the drug discover informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Drug Discovery Informatics Market?

The drug discovery informatics market consists of revenues earned by entities by providing literature databases, chemical databases, biological databases, predictive analytics, structures 2D and 3D, pharmacokinetic and pharmacodynamic data analysis, assay data analysis, genomics data analytics, and proteomics data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery informatics market also includes sales of CI-based (continuous integration) design tools and pharmacophore modelling tools, which are used in providing drug discovery informatics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Discovery Informatics Market Report 2026?

The drug discovery informatics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery informatics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.